Abstract:Background: Human herpesvirus 6 (HHV-6) is considered a ubiquitous virus, with many countries reporting a seroprevalence of more than 80-90% among the general population. However, this virus is unique among herpesviruses in its ability to integrate into the genetic material of the host's cells. Thus, there are three ways by which HHV-6 can cause an active infection-primary infection, reactivation of a latent acquired infection, or activation of iciHHV-6 (inherited chromosomally integrated HHV-6). Whole blood quantitative polymerase chain reaction (qPCR) is very useful in distinguishing between iciHHV-6 and primary infection/reactivation. Our aim is to assess the role of HHV-6 in the aetiology of central nervous system (CNS) infections in adults and children, to describe all HHV-6-positive cases in an attempt to determine the susceptible population and to identify potential risk factors that can be linked to HHV-6 meningoencephalitis. Methods: We performed a retrospective study involving patients that were admitted to Prof. Dr. Matei Bals National Institute of Infectious Diseases, Bucharest, Romania, with a diagnosis of meningitis or encephalitis. We only selected the clinical records of patients that had a multiplex PCR Biofire® FilmArray® meningitis/encephalitis panel. Results: We report a 5% HHV-6 positivity in the cerebrospinal fluid (CSF) of patients with CNS infections tested with a commercial multiplex PCR M/E (meningitis/encephalitis) panel. Additionally, 2% to 4% of the total study population (n = 100) had active HHV-6 infections, which denotes 40 to 80% of the HHV-6-positive samples. We did not observe any statistically significant correlation between HHV-6 positivity in the CSF and variables such as age, sex, or comorbidities, including obesity, diabetes, hypertension, immunosuppression, or oncologic disease. Therefore, no risk factors could be linked with HHV-6 positivity in the CSF. Conclusions: although multiplex qualitative PCR is highly useful for providing rapid results and identifying nearly every pathogen that can cause meningitis/encephalitis, we have to be aware of this type of test's limitations. All patients with HHV-6 detectable in their CSF via a multiplex PCR test should also undergo qPCR testing from both CSF and blood to prevent over-diagnosing HHV-6 CNS infections, to avoid unnecessary antiviral treatments, and ensure the accurate identification of the true diagnosis.

Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy

Establishment and clinical application of a new real time PCR assay for simultaneous detection of human herpesvirus-6A and human herpesvirus-6B

Subtype-Specific, Probe-Based, Real-Time Pcr for Detection and Typing of Human Herpesvirus-6 Encephalitis from Pediatric Patients under the Age of 2 Years

Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain

Determination of the Six Major Human Herpesviruses in Cerebrospinal Fluid and Blood Specimens of Children

Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases

Human Herpesvirus 6-A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation?

Rapid Diagnosis of Herpetic Encephalitis in Children by PCR-microarray Technology for Simultaneous Detection of Seven Human Herpes Viruses

Amplification and Detection of the Six Major Heperviruses by PCR-based Assay

Association of Human Herpesvirus-6B with Mesial Temporal Lobe Epilepsy

Human herpesvirus 6 and epilepsy

Metagenomic search of viral coinfections in herpes simplex encephalitis patients

Tissue specific signature of HHV-6 infection in ME/CFS

Latent, early or late HHV-6B expression in adult mesial temporal lobe epilepsy: Association of virus life cycle with inflammatory cytokinesin brain tissue and cerebral spinal fluid

Title: Latent, early or late HHV-6B expression in adult mesial temporal lobe epilepsy: Association of virus life cycle with inflammatory cytokines in brain tissue and cerebral spinal fluid

Validation of Α-Herpes Viruses in Cerebrospinal Fluid from Patients with Intracranial Infection by Next-Generation Sequencing

Metagenomic Next-Generation Sequencing (mNGS) of cerebrospinal fluid for diagnosis of human herpesvirus 6B encephalitis following transplantation for severe aplastic anemia

Unveiling the Impact of Human Herpesviruses-Associated on CNS Infections: An Observational Study

Clinical and Laboratory Findings That Differentiate Herpes Simplex Virus Central Nervous System Disease from Enteroviral Meningitis

Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy.

Human Herpesvirus 6 (HHV-6) Encephalitis in a Non-Transplant Patient With Polymyositis